DNAVSLABT• 3 Months (Normalized)
DNA vs LABT (Ginkgo Bioworks Holdings Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
LABT Performance $0.99
-64%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+64 pts
DNA outperforming by 64.00 percentage points
DNALABT
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | DNA Price | DNA Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $0.99 | -64.00% | - | |
| Sep 28, 2026 | $10.46 | +0.58% | $1.15 | -58.18% | +58.76% |
| Sep 25, 2026 | $10.66 | +2.50% | $1.67 | -39.27% | +41.77% |
| Sep 24, 2026 | $10.25 | -1.44% | $1.83 | -33.45% | +32.01% |
| Sep 23, 2026 | $8.58 | -17.50% | $1.78 | -35.27% | +17.77% |
| Sep 22, 2026 | $9.37 | -9.90% | $1.99 | -27.64% | +17.74% |
| Sep 21, 2026 | $7.98 | -23.27% | $2.05 | -25.45% | +2.18% |
| Sep 18, 2026 | $7.88 | -24.23% | $1.99 | -27.64% | +3.41% |
| Sep 17, 2026 | $7.84 | -24.62% | $1.86 | -32.36% | +7.74% |
| Sep 16, 2026 | $7.06 | -32.12% | $2.09 | -24.00% | -8.12% |
| Sep 15, 2026 | $6.99 | -32.79% | $2.17 | -21.09% | -11.70% |
| Sep 14, 2026 | $7.01 | -32.60% | $2.12 | -22.91% | -9.69% |
| Sep 11, 2026 | $6.75 | -35.10% | $2.22 | -19.27% | -15.83% |
| Sep 10, 2026 | $6.78 | -34.81% | $2.05 | -25.45% | -9.36% |
| Sep 09, 2026 | $6.79 | -34.71% | $2.32 | -15.64% | -19.07% |
Page 1 of 5